Hazelaar, Daan M.
Boers, Ruben G.
Boers, Joachim B.
de Weerd, Vanja
Helmijr, Jean
PHM Jansen, Maurice
MW Verheul, Henk
Verhoef, Cornelis
Gribnau, Joost
Martens, John WM
Makrodimitris, Stavros
Wilting, Saskia M.
Funding for this research was provided by:
the Dutch MDL Foundation (SK18-02))
the Dutch Cancer Society (KWF14976)
Article History
Received: 27 May 2025
Accepted: 30 November 2025
First Online: 15 December 2025
Competing interests
: RGB, JBB, and JG report being shareholders in Methylomics B.V., a commercial company that applies MeD-seq. The other authors do not have a competing interest.